Form 4 for ASTH Astrana Health, Inc.
Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-16 · accession 0001250853-23-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-25 | 2023-05-16 | ASTH | Sim Brandon | Co-CEO | A - Grant | $0.00 | +380.1K | 902.6K | +73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-16 | A | A | 380,053 | $0.00 | 902,620 | D | — | — | (F1) Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 136,819 of the shares shall vest in eight equal (as nearly as possible) semi-annual installments, beginning on March 31, 2023. The remaining 243,234 shares shall vest upon achievement of certain pre-established performance goals. |